Evidence map›Paper›PMID 32546914›Full record

ArticleVeterinary world2019

Effect of cocoa powder on hypertension and antioxidant status in uninephrectomized hypertensive rats.

Olayinka Christianah Jayeola, Ademola Adetokunbo Oyagbemi, Omolara Ibiwunmi Okunlola, Olayiwola Olubamiwa, Temidayo Olutayo Omobowale, Temitayo Olabisi Ajibade, Foluso Bolawaye Bolaji-Alabi, Blessing Seun Ogunpolu, Olufunke Olubunmi Falayi, Adebowale Benard Saba and 4 more

Open access · goldAbstract read
In one paragraph

Article in Veterinary world, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 2 countries.

Olayinka Christianah JayeolaCocoa Research Institute of Nigeria, P.M.B 5244, Ibadan, Oyo State, Nigeria.
Ademola Adetokunbo OyagbemiDepartment of Veterinary Physiology and Biochemistry, Faculty of Veterinary Medicine, University of Ibadan, Ibadan, Nigeria.
Omolara Ibiwunmi OkunlolaStandard Organization of Nigeria, Block 7, Obafemi Awolowo Way, Alausa Ikeja, Lagos, Nigeria.
Olayiwola OlubamiwaCocoa Research Institute of Nigeria, P.M.B 5244, Ibadan, Oyo State, Nigeria.
Temidayo Olutayo OmobowaleDepartment of Veterinary Medicine, Faculty of Veterinary Medicine, University of Ibadan, Nigeria.
Temitayo Olabisi AjibadeDepartment of Veterinary Physiology and Biochemistry, Faculty of Veterinary Medicine, University of Ibadan, Ibadan, Nigeria.
Foluso Bolawaye Bolaji-AlabiDepartment of Veterinary Theriogenology, Faculty of Veterinary Medicine, University of Ibadan, Ibadan, Nigeria.
Blessing Seun OgunpoluDepartment of Veterinary Medicine, Faculty of Veterinary Medicine, University of Ibadan, Nigeria.
Olufunke Olubunmi FalayiDepartment of Veterinary Pharmacology and Toxicology, Faculty of Veterinary Medicine, University of Ibadan, Ibadan, Nigeria.
Adebowale Benard SabaDepartment of Veterinary Pharmacology and Toxicology, Faculty of Veterinary Medicine, University of Ibadan, Ibadan, Nigeria.
Adeolu Alex AdedapoDepartment of Veterinary Pharmacology and Toxicology, Faculty of Veterinary Medicine, University of Ibadan, Ibadan, Nigeria.
Momoh Audu YakubuDepartment of Environmental and Interdisciplinary Sciences, College of Science, Engineering and Technology, Vascular Biology Unit, Center for Cardiovascular Diseases, College of Pharmacy and Health Sciences (COPHS), Texas Southern University, Houston, Texas, USA.
Afolabi OluwadunDepartment of Medical Microbiology, Olabisi Onabanjo University, Sagamu Campus, Sagamu, Nigeria.
Oluwafemi Omoniyi OguntibejuPhytomedicine and Phytochemistry Group, Department of Biomedical Sciences, Faculty of Health and Wellness Sciences, Cape Peninsula University of Technology, Bellville 7535, South Africa.
University of Ibadan · NGCape Peninsula University of Technology · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimHigh salt diet and uninephrectomy are associated with high blood pressure with attendant cardiovascular disease conditions such as hypertension, renal damage, myocardial infarction, and stroke. The aim of this study was to investigate the beneficial effects of consumption of cocoa and cocoa-containing products in the management of high blood pressure in uninephrectomized hypertensive rats. MATERIALS AND

methodsThe effect of cocoa powder on blood pressure, markers of inflammation, oxidative stress, and histopathology were investigated in uninephrectomized animals fed with cocoa feed alone or in combination with a high salt diet. Male rats were randomly divided into five groups: Group A was the control group and fed with normal feed alone, Group B was fed with cocoa feed alone, Group C was fed with high salt diet (8% salt), GroupD was fed with cocoa-feed compounded with 8% salt for 4weeks after uninephrectomy, and GroupE was uninephrectomized rats on a normal diet. The left kidneys of animals in GroupsC, D, and E were removed by surgery. After 4weeks of treatment, the systolic, diastolic, and mean arterial blood pressure was measured. The serum markers of renal damage and oxidative stress were determined. Histological examination was also performed on renal and cardiac tissues.

resultsResults showed significant increases in biomarkers of oxidative stress, inflammation, and renal damage with a concomitant decrease in antioxidant status in hypertensive uninephrectomized rats. Cocoa feed, however, significantly improved blood pressure and nitric oxide bioavailability, antioxidant status and reduced markers of inflammation and oxidative stress.

conclusionThese findings show that cocoa powder could be used to maintain blood pressure levels in hypertensive rats through its antioxidant capacity.

Indexed as

antioxidant therapycocoa powderhigh salt diethypertensionoxidative stress

Identifiers

PMID32546914
PMCPMC7245715
OpenAlexW3016496096

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.